- Home
- RPRX vs L Comparison
RPRX vs L Comparison
Compare RPRX & L Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | L |
|---|---|---|
| Founded | 1996 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 22.0B |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | RPRX | L |
|---|---|---|
| Price | $46.15 | $108.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $47.75 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 570.0K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.06% | 0.23% |
| EPS Growth | N/A | ★ 24.34 |
| EPS | 1.78 | ★ 7.97 |
| Revenue | $2,378,193,000.00 | ★ $18,454,000,000.00 |
| Revenue This Year | $38.30 | N/A |
| Revenue Next Year | $4.80 | N/A |
| P/E Ratio | $25.63 | ★ $13.55 |
| Revenue Growth | 5.06 | ★ 5.39 |
| 52 Week Low | $29.66 | $78.98 |
| 52 Week High | $47.86 | $114.90 |
Technical Indicators
Market Signals| Indicator | RPRX | L |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 49.12 |
| Support Level | $44.94 | $107.84 |
| Resistance Level | $46.14 | $112.32 |
| Average True Range (ATR) | 0.92 | 1.98 |
| MACD | -0.23 | -0.40 |
| Stochastic Oscillator | 39.36 | 27.74 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.